Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach

Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach

Emerging research demonstrates that co-inhibitory immune checkpoints (ICs) remain the most promising immunotherapy targets in various malignancies. Nonetheless, ICIs have offered insignificant clinical benefits in the treatment of advanced prostate cancer (PCa) especially when they are used as monot...

Full description

Bibliographic Details
Main Authors: Mankgopo M. Kgatle, Tebatso M. G. Boshomane, Ismaheel O. Lawal, Kgomotso M. G. Mokoala, Neo P. Mokgoro, Nico Lourens, Kalevo Kairemo, Jan Rijn Zeevaart, Mariza Vorster, Mike M. Sathekge
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
immune checkpoints
immune checkpoints inhibitors
immunotherapy
metastatic hormone resistance prostate cancer
metastatic hormone sensitive prostate cancer
prostate cancer
Online Access:https://www.mdpi.com/1422-0067/22/8/4109

Internet

https://www.mdpi.com/1422-0067/22/8/4109

Similar Items